Press Releases

Featured Press Releases

BIO Applauds Introduction of Bipartisan…

BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…

Learn more

BIO International Convention Celebrates Another…

Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…

Learn more

BIO Recognizes Industry Leaders for…

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…

Learn more

PAHPA committee votes "important step forward" in public health preparedness

July 20, 2023

Two Congressional committees this week pushed through legislation to reauthorize the Pandemic All Hazards and Preparedness Act (PAHPA). Following the votes, Phyllis Arthur -- Senior Vice President, Infectious Diseases & Emerging Science…

Reasonable Pricing Clause in PAHPA Undermines Ability To Protect Country And Prepare for Future Pandemics

July 3, 2023

The Senate HELP Committee today released a discussion draft of legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). BIO represents many small- and mid-size companies that are at the heart of the type of public-private…

New CMS guidance a "missed opportunity" for future medical innovation, patients

June 30, 2023

The Centers for Medicare & Medicaid Services (CMS) today released its guidance for the Drug Price Negotiation Program (Negotiation Program) under the Inflation Reduction Act of 2022 (IRA). John Murphy, BIO’s Chief Policy Officer, made the…

BIO: Delay of R&D Tax Burden is Positive Step, Permanent Repeal Still Needed

June 15, 2023

The House Ways & Means Committee has approved a bill that includes language to delay retroactively through 2025 the mandatory capitalization of research and development expenses, which took effect in tax year 2022. The Tax Cuts and Jobs Act of…

The Coalition of State Bioscience Institutes (CSBI) Releases the 2023 Life Sciences Workforce Trends Report at BIO International Convention

June 7, 2023

"The intense competition for talent in 2021, 2022 and into early 2023 extended to the life sciences as the nation’s overall unemployment rate reached …

Massachusetts Speaker of the House Ron Mariano Honored as BIO Legislative Champion

June 6, 2023

Today, the Biotechnology Innovation Organization (BIO) presented Speaker of the Massachusetts House of Representatives Ronald J. Mariano with BIO’s Legislative Champion Award. Speaker Mariano received the award in conjunction with the BIO…

New Report Explores Latest Best Practices in State Bioscience Economic Development Initiatives

June 6, 2023

Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences…

BIO Elects Dr. Ted W. Love as New Board Chair

June 5, 2023

2023-2024 BIO Executive Committee is Accomplished, Energetic and Diverse Boston, Mass. (June 5, 2023) – Biotechnology Innovation Organization (BIO) is proud to announce its newly elected Executive Committee Directors following Board elections that…

BIO Applauds USTR for Taking Next Step to Return Mexico to Science-Based Policy

June 2, 2023

The following statement may be attributed to Nancy Travis, vice president for international affairs, BIO. “The Biotechnology Innovation Organization supports the decision, announced today, by the Office of the U.S. Trade Representative to request…

BIO Statement on PIPs Rule: EPA Misses Opportunity to Advance Food, Ag Innovation

May 25, 2023

The following statement concerning the Environmental Protection Agency’s final rule on regulation of Plant Incorporated Protectants (PIPs) under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) may be attributed to John Murphy, chief…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.